Jefferies Financial Group Begins Coverage on ICU Medical (NASDAQ:ICUI)

Jefferies Financial Group started coverage on shares of ICU Medical (NASDAQ:ICUI) in a research note released on Monday morning, MarketBeat reports. The brokerage issued a hold rating and a $183.00 price objective on the medical instruments supplier’s stock.

Several other analysts also recently commented on ICUI. Raymond James upped their price objective on shares of ICU Medical from $158.00 to $190.00 and gave the company an “outperform” rating in a report on Thursday, September 12th. KeyCorp increased their price target on ICU Medical from $136.00 to $147.00 and gave the stock an “overweight” rating in a research report on Thursday, August 8th. StockNews.com raised ICU Medical from a “hold” rating to a “buy” rating in a report on Thursday, September 12th. Finally, Needham & Company LLC reaffirmed a “hold” rating on shares of ICU Medical in a report on Thursday, October 10th. Two analysts have rated the stock with a hold rating and four have given a buy rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $170.25.

ICU Medical Price Performance

NASDAQ ICUI opened at $183.83 on Monday. The company has a market cap of $4.48 billion, a price-to-earnings ratio of -75.03 and a beta of 0.66. The company has a debt-to-equity ratio of 0.76, a current ratio of 2.41 and a quick ratio of 1.08. The stock’s fifty day moving average price is $168.94 and its 200 day moving average price is $131.20. ICU Medical has a 1 year low of $78.28 and a 1 year high of $188.53.

ICU Medical (NASDAQ:ICUI) last announced its quarterly earnings data on Wednesday, August 7th. The medical instruments supplier reported $1.56 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.00 by $0.56. The firm had revenue of $596.50 million during the quarter, compared to analysts’ expectations of $556.64 million. ICU Medical had a positive return on equity of 5.01% and a negative net margin of 3.07%. The company’s revenue for the quarter was up 8.6% compared to the same quarter last year. During the same period last year, the business posted $1.58 earnings per share. As a group, equities research analysts forecast that ICU Medical will post 3.76 earnings per share for the current year.

Insiders Place Their Bets

In other news, CEO Vivek Jain sold 12,000 shares of the firm’s stock in a transaction dated Friday, August 16th. The stock was sold at an average price of $156.04, for a total transaction of $1,872,480.00. Following the sale, the chief executive officer now directly owns 104,593 shares in the company, valued at $16,320,691.72. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. In other news, CEO Vivek Jain sold 12,000 shares of the stock in a transaction that occurred on Friday, August 16th. The stock was sold at an average price of $156.04, for a total transaction of $1,872,480.00. Following the transaction, the chief executive officer now owns 104,593 shares in the company, valued at $16,320,691.72. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, VP Daniel Woolson sold 2,502 shares of ICU Medical stock in a transaction on Friday, August 30th. The shares were sold at an average price of $163.22, for a total transaction of $408,376.44. Following the completion of the sale, the vice president now directly owns 13,107 shares in the company, valued at $2,139,324.54. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders sold 40,552 shares of company stock worth $6,679,322. Company insiders own 6.70% of the company’s stock.

Institutional Inflows and Outflows

Hedge funds have recently modified their holdings of the stock. Vanguard Group Inc. boosted its holdings in ICU Medical by 14.8% in the 4th quarter. Vanguard Group Inc. now owns 2,440,729 shares of the medical instruments supplier’s stock worth $243,438,000 after buying an additional 315,103 shares during the last quarter. Silvercrest Asset Management Group LLC boosted its stake in shares of ICU Medical by 109.4% in the first quarter. Silvercrest Asset Management Group LLC now owns 278,436 shares of the medical instruments supplier’s stock worth $29,882,000 after acquiring an additional 145,485 shares during the last quarter. Mesirow Institutional Investment Management Inc. purchased a new stake in shares of ICU Medical during the first quarter worth approximately $15,425,000. Victory Capital Management Inc. raised its stake in ICU Medical by 2,966.3% in the 2nd quarter. Victory Capital Management Inc. now owns 141,848 shares of the medical instruments supplier’s stock valued at $16,844,000 after purchasing an additional 137,222 shares during the last quarter. Finally, Millennium Management LLC lifted its holdings in ICU Medical by 327.8% in the 2nd quarter. Millennium Management LLC now owns 136,070 shares of the medical instruments supplier’s stock valued at $16,158,000 after purchasing an additional 104,264 shares in the last quarter. Institutional investors and hedge funds own 96.10% of the company’s stock.

About ICU Medical

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.